01 4Parasbiv
02 8Parsabiv
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2020 Revenue in Millions : 716
2019 Revenue in Millions : 630
Growth (%) : 14
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2021 Revenue in Millions : 280
2020 Revenue in Millions : 716
Growth (%) : -61
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2020 Revenue in Millions : 75
2019 Revenue in Millions : 65
Growth (%) : 16
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2021 Revenue in Millions : 73
2020 Revenue in Millions : 72
Growth (%) : 10
Main Therapeutic Indication : Endocrinology
Currency : USD
2022 Revenue in Millions : 382
2021 Revenue in Millions : 280
Growth (%) : 36
Main Therapeutic Indication : Endocrinology
Currency : USD
2022 Revenue in Millions : 65
2021 Revenue in Millions : 73
Growth (%) : -12
Main Therapeutic Indication : Endocrinology
Currency : USD
2023 Revenue in Millions : 56
2022 Revenue in Millions : 65
Growth (%) : -1
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2018 Revenue in Millions : 336
2017 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2019 Revenue in Millions : 630
2018 Revenue in Millions : 336
Growth (%) : 88
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2017 Revenue in Millions : 43
2016 Revenue in Millions : Not Available
Growth (%) : Not Available
LOOKING FOR A SUPPLIER?